Loading clinical trials...

The Feasibility and Examination of the Effects of Floatation-based REST on a Community Sample With PTSD | Clinical Trials | Clareo Health

ACTIVE_NOT_RECRUITINGNA

The Feasibility and Examination of the Effects of Floatation-based REST on a Community Sample With PTSD

The Feasibility and Examination of the Effects of Floatation-based Reduced Environmental Stimulation Therapy (REST) on a Community Sample With Posttraumatic Stress Disorder (PTSD)

NCT04368689•Medical College of Wisconsin

View on ClinicalTrials.gov

Summary

This project is being done to explore the effects floating has on individuals who have a history of trauma with stress related symptoms.

Detailed Description

This pilot study looks to further the current floatation-based REST literature by exploring the therapy's effectiveness within a community-based sample of adults with PTSD. This type of sample allows the study the opportunity to recruit both veteran and civilian subjects, two populations that can suffer from this clinical diagnosis and stand to benefit from this therapy. This study will: 1. Evaluate the psychological effects of floating for a clinical, community sample with PTSD. 2. Evaluate the physiological effects of floating for a clinical, community sample with PTSD. 3. Evaluate the subjective effects of floating for a clinical, community sample with PTSD.

Eligibility

Age

18 - 60 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Has posttraumatic stress disorder (PTSD) as confirmed by the PCL-5
•18-60 years of age

Exclusion Criteria

•History of neurological conditions (e.g., epilepsy, stroke, severe traumatic brain injury, Parkinson's disease, Alzheimer's disease or other forms of dementia)
•Any skin conditions or open wounds that could cause pain when exposed to saltwater
•Has floated previously
•Has Schizophrenia spectrum or other psychotic disorders
•Refuses to adhere to the Pre-Float Checklist
•Non-English speaking
•Inability to lay comfortably in a shallow pool of water
•Refuses participation in the floatation-REST sessions
•Refuses to sign the Float Liability Waiver prior to floating
•No Communicable disease (e.g.- HIV, Hepatitis A, B\& C, tuberculosis, or measles)
+6 more criteria

Locations (1)

Medical College of Wisconsin

Milwaukee, Wisconsin, United States

Key Dates

Start Date

June 18, 2021

Primary Completion Date

December 1, 2027

Completion Date

December 1, 2027

Last Updated

January 21, 2026

Enrollment

ESTIMATED participants

Conditions

Post-Traumatic Stress Disorders

Interventions

Floatation-based reduced environmental stimulation therapy

OTHER

Mental Health in Veterans and Families After Group Therapies

NCT01327690

Post-Traumatic Stress Disorders

View study

COMPLETEDPHASE1

Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans

NCT04032301

Post-Traumatic Stress DisordersMajor Depressive Disorder

View study

COMPLETEDNA

Trauma Informed Guilt Reduction Therapy

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 21, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

The Feasibility and Examination of the Effects of Floatation-based REST on a Community Sample With PTSD

Inclusion Criteria

Exclusion Criteria

Mental Health in Veterans and Families After Group Therapies

Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans

Trauma Informed Guilt Reduction Therapy

To Evaluate the Efficacy of EEG-guided Magnetic Resonant Therapy in War Veterans With Posttraumatic Stress Disorder

Telemedicine Management of Chronic Insomnia

Obstructive Sleep Apnea and Arousal Threshold in Patients With Post-traumatic Stress Disorder